Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check5 days agoChange DetectedNew latest revision entry v3.6.6 has been added to the Study Record History, replacing the prior v3.6.5. This documents an updated revision of the record on ClinicalTrials.gov.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry (v3.6.5) appears, replacing the previous revision (v3.6.4) in the study record history. This reflects a maintenance update to the page's revision metadata.SummaryDifference0.1%

- Check41 days agoChange DetectedThe study record history now shows Revision: v3.6.4 as the latest entry, replacing v3.6.3. This indicates a site update and does not modify the study details or results.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the Study Record History, and the previous v3.6.2 entry was removed. This reflects an update to the page's revision history in the study's record.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the history and the previous 'Revision: v3.6.0' was removed. This reflects an update to the page's revision metadata.SummaryDifference0.1%

- Check84 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment is closed. The record history shows a new Revision: v3.6.0 and the removal of Revision: v3.5.5.SummaryDifference0.4%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.